Bellerophon Therapeutics, Inc

(NASDAQ:BLPH)

Latest On Bellerophon Therapeutics, Inc (BLPH):

Date/Time Type Description Signal Details
2023-05-15 21:34 ESTNewsBellerophon Therapeutics GAAP EPS of $0.27, revenue of $5.64MN/A
2023-03-31 17:54 ESTNewsBellerophon Therapeutics GAAP EPS of -$2.08 misses by $0.06N/A
2023-03-06 11:35 ESTNewsBellerophon Therapeutics to raise $5M in stock and warrants offeringN/A
2023-02-09 22:17 ESTNewsBellerophon gets green light from China NMPA to conduct phase 3 trial of fibrotic interstitial lung disease treatmentN/A
2023-01-18 17:03 ESTNewsBellerophon up 14% as enrollment finishes in trial for fibrotic interstitial lung disease therapyN/A
2023-01-05 20:48 ESTNewsBellerophon stock rockets +100% on a license and commercialization deal in ChinaN/A
2022-11-14 23:21 ESTNewsBellerophon Therapeutics GAAP EPS of -$0.53 beats by $0.05N/A
2022-09-28 00:37 ESTNewsBellerophon stock gains ~24% after getting FDA nod to reduce phase 3 study sizeN/A
2022-08-15 11:56 ESTNewsBellerophon Therapeutics GAAP EPS of -$0.43 beats by $0.17N/A
2022-05-11 20:17 ESTNewsBellerophon Therapeutics GAAP EPS of -$0.59 misses by $0.04N/A
2022-04-01 03:32 ESTNewsBellerophon Therapeutics GAAP EPS of -$1.87N/A
2021-11-15 21:41 ESTNewsBellerophon Therapeutics EPS beats by $0.14N/A
2021-09-19 04:23 ESTNewsBellerophon Therapeutics (BLPH ) Investor Presentation - SlideshowN/A
2021-08-05 23:07 ESTNewsBellerophon Therapeutics EPS beats by $0.25N/A
2021-07-20 21:43 ESTNewsBellerophon Therapeutics and Entera Bio among healthcare gainers; Second Sight Medical Products and Adial Pharmaceuticals among losersN/A
2021-03-16 20:19 ESTEarnings EstimateAn EPS average of -$0.68 is estimated for the quarter ending on March 31, 2021.Buy
2021-03-12 21:18 ESTNewsBellerophon Therapeutics (BLPH) Investor Presentation - SlideshowN/A
2021-03-12 07:15 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 03:16 ESTEarnings EstimateAn EPS average of -$2.19 is estimated for the 2022 year.Sell
2021-03-12 03:16 ESTEarnings EstimateAn EPS average of -$0.74 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-12 00:22 ESTNewsBellerophon Therapeutics EPS beats by $0.17N/A
2021-01-06 11:15 ESTAnalyst RatingThe Analyst Target Price has decreased from $26.5 to $23.67.Neutral
2021-01-02 15:16 ESTFinancialsCompany financials have been released.Neutral
2020-12-13 03:22 ESTFinancialsCompany financials have been released.Neutral
2020-12-01 12:20 ESTNewsBellerophon launches late-stage study of INOpulse in lung-scarring diseasesN/A
2020-11-15 11:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 22:27 ESTNewsAcceleron's sotatercept shows positive action in mid-stage pulmonary arterial hypertension studiesN/A
2020-11-10 03:18 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 03:39 ESTNewsBellerophon Therapeutics EPS misses by $0.01N/A
2020-11-01 17:20 ESTFinancialsCompany financials have been released.Neutral
2020-09-24 00:16 ESTFinancialsCompany financials have been released.Neutral
2020-09-14 09:02 ESTInsider TradeWassim FARES has directly acquired 4,000 shares and currently holds 4,000 shares.Buy
2020-09-04 12:15 ESTAnalyst RatingThe Analyst Target Price has decreased from $28.5 to $26.5.Neutral
2020-08-13 08:16 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.67 to $28.5.Neutral
2020-08-07 00:18 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 11:56 ESTNewsBellerophon Therapeutics EPS beats by $0.21N/A
2020-07-31 00:22 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 12:18 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-14 06:12 ESTNewsBellerophon advances late-stage study of INOpulse for COVID-19N/A
2020-07-10 08:16 ESTFinancialsCompany financials have been released.Neutral
2020-06-29 18:31 ESTNewsRussell adds lineup of healthcare firms to key indexesN/A
2020-06-27 13:55 ESTNewsBellerophon Therapeutics files for $150M mixed shelfN/A
2020-06-09 17:48 ESTInsider TradeTheodore T Wang has directly acquired 2,600 shares and currently holds 60,913 shares.Buy
2020-06-09 17:48 ESTInsider TradeTheodore T Wang has directly acquired 4,986 shares and currently holds 58,313 shares.Buy
2020-06-02 08:15 ESTEarnings EstimateAn EPS average of -$0.47 is estimated for the quarter ending on September 30, 2020.Buy
2020-05-31 16:44 ESTFinancialsCompany financials have been released.Neutral
2020-05-22 07:46 ESTInsider TradeLife Science Opportunities Fund VI Puissance has directly acquired 1,153,846 shares and currently holds 1,153,846 shares.Buy
2020-05-21 05:19 ESTNewsBellerophon down 13% after pricing stock offeringN/A
2020-05-18 21:15 ESTNewsBellerophon initiates stock offeringN/A

About Bellerophon Therapeutics, Inc (BLPH):

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its products include INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 2 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; that has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that is in Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension, pulmonary hypertension associated with pulmonary edema from high altitude sickness, and COVID-19 patients. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

BLPH Quotes by TradingView

See Advanced Chart

General

  • Name Bellerophon Therapeutics, Inc
  • Symbol BLPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 21
  • Last Split Factor1:15
  • Last Split Date2020-02-10
  • Fiscal Year EndDecember
  • IPO Date2015-02-13
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.bellerophon.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 1.69
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.75
  • Next Year EPS Estimate -$2.27
  • Return on Assets -41%
  • Return on Equity -118%
  • Earnings Per Share $0.09
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 61.22 million
  • EBITDA -19725000
  • Analyst Target Price $23.67
  • Book Value Per Share $4.03
View More

Share Statistics

  • Shares Outstanding 9.49 million
  • Shares Float 6.59 million
  • % Held by Insiders 763%
  • % Held by Institutions 43.82%
  • Shares Short 298705
  • Shares Short Prior Month 258756
  • Short Ratio 3.22
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta -0.44
  • 52 Week High $21
  • 52 Week Low $5.85
  • 50 Day Moving Average 7.12
  • 200 Day Moving Average 8.13
View More

Dividends

  • Dividend Date 2020-02-10
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Bellerophon Therapeutics, Inc (BLPH) Dividend Calendar:

BLPH's last dividend payment was made to shareholders on February 10, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Bellerophon Therapeutics, Inc (BLPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.86-$0.904.79%
2020-09-302020-11-05$N/A-$0.84-$0.83-0.9%
2020-06-302020-08-05$N/A-$0.51-$0.7229.17%
2020-03-312020-04-06$N/A-$1.00-$1.054.76%
2019-12-312019-12-31$N/A-$1.00-$1.054.76%
2019-09-302019-11-06$N/A-$0.90-$0.987.69%
2019-06-302019-08-08$N/A-$0.90-$0.85-5.88%
2019-03-312019-05-09$N/A-$0.15-$1.5090%
2018-12-312019-03-14$N/A-$0.20-$2.1090.49%
2018-09-302018-11-07$N/A$2.55-$1.80241.67%
2018-06-302018-08-01$N/A-$3.00-$1.50-100%
2018-03-312018-05-10$N/A$0.85-$2.10140.57%
2017-12-312018-03-15$N/A-$6.60-$0.22-2900%
2017-09-302017-11-07$N/A-$3.30-$3.300%
2017-06-302017-08-07$N/A-$1.80-$2.2520%
2017-03-312017-05-15$N/A-$9.00-$3.75-140%
2016-12-312017-03-13$N/A-$5.55-$3.15-76.19%
2016-09-302016-11-08$N/A-$4.50-$6.2528%
2016-06-302016-08-09$N/A-$5.85-$7.6523.53%
2016-03-312016-05-10$N/A-$8.10-$9.7917.24%
2015-12-312016-03-21$N/A-$11.40-$15.9428.47%
2015-09-302015-11-12$N/A-$0.86-$0.948.51%
2015-06-302015-08-13$N/A-$0.90-$1.0816.67%
2015-03-312015-05-15$N/A-$1.27-$1.25-1.6%
2014-12-312015-03-16$N/A-$1.62-$1.9516.92%

Bellerophon Therapeutics, Inc (BLPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Bellerophon Therapeutics, Inc (BLPH) Chart:

Bellerophon Therapeutics, Inc (BLPH) News:

Below you will find a list of latest news for Bellerophon Therapeutics, Inc (BLPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Bellerophon Therapeutics, Inc (BLPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest BLPH Trades:

Date Shares Price
Jun 13, 2022 6:09 PM EST100$0.8595
Jun 13, 2022 6:09 PM EST5$0.879
Jun 13, 2022 6:09 PM EST5$0.899
Jun 13, 2022 6:09 PM EST100$0.951

Bellerophon Therapeutics, Inc (BLPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1600132/000160013220000070/0001600132-20-000070-index.htm
2020-07-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600132/000000000020005888/0000000000-20-005888-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600132/000089534519000100/0000895345-19-000100-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600132/000089534520000107/0000895345-20-000107-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600132/000110465919008695/0001104659-19-008695-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600132/000110465920021689/0001104659-20-021689-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600132/000110465920063155/0001104659-20-063155-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600132/000110465920064223/0001104659-20-064223-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600132/000110465920064227/0001104659-20-064227-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000110465920064230/0001104659-20-064230-index.htm
2020-07-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600132/000110465920084551/0001104659-20-084551-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000110465920084552/0001104659-20-084552-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000120919119019526/0001209191-19-019526-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000120919119019528/0001209191-19-019528-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000120919119054264/0001209191-19-054264-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000120919119054265/0001209191-19-054265-index.htm
2020-03-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600132/000153561020000083/0001535610-20-000083-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000145/0001600132-18-000145-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000146/0001600132-18-000146-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000147/0001600132-18-000147-index.htm
2018-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000149/0001600132-18-000149-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000151/0001600132-18-000151-index.htm
2018-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000155/0001600132-18-000155-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000157/0001600132-18-000157-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600132/000160013218000164/0001600132-18-000164-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000165/0001600132-18-000165-index.htm
2018-11-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000176/0001600132-18-000176-index.htm
2018-11-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000177/0001600132-18-000177-index.htm
2018-11-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000178/0001600132-18-000178-index.htm
2018-11-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000179/0001600132-18-000179-index.htm
2018-11-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000180/0001600132-18-000180-index.htm
2018-11-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013218000181/0001600132-18-000181-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000012/0001600132-19-000012-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000013/0001600132-19-000013-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000014/0001600132-19-000014-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000015/0001600132-19-000015-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000016/0001600132-19-000016-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000017/0001600132-19-000017-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000020/0001600132-19-000020-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000021/0001600132-19-000021-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600132/000160013219000024/0001600132-19-000024-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000031/0001600132-19-000031-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600132/000160013219000032/0001600132-19-000032-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000041/0001600132-19-000041-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000042/0001600132-19-000042-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000043/0001600132-19-000043-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000044/0001600132-19-000044-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000047/0001600132-19-000047-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000049/0001600132-19-000049-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1600132/000160013219000056/0001600132-19-000056-index.htm
2019-03-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000057/0001600132-19-000057-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000061/0001600132-19-000061-index.htm
2019-03-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000062/0001600132-19-000062-index.htm
2019-03-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000063/0001600132-19-000063-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000065/0001600132-19-000065-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600132/000160013219000070/0001600132-19-000070-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000071/0001600132-19-000071-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000074/0001600132-19-000074-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000080/0001600132-19-000080-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000084/0001600132-19-000084-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000085/0001600132-19-000085-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000086/0001600132-19-000086-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000090/0001600132-19-000090-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000091/0001600132-19-000091-index.htm
2019-06-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000093/0001600132-19-000093-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000095/0001600132-19-000095-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000097/0001600132-19-000097-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000100/0001600132-19-000100-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000102/0001600132-19-000102-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600132/000160013219000105/0001600132-19-000105-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000106/0001600132-19-000106-index.htm
2019-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000108/0001600132-19-000108-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000110/0001600132-19-000110-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000124/0001600132-19-000124-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000125/0001600132-19-000125-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000126/0001600132-19-000126-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000127/0001600132-19-000127-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000128/0001600132-19-000128-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000129/0001600132-19-000129-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000130/0001600132-19-000130-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000131/0001600132-19-000131-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000132/0001600132-19-000132-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000133/0001600132-19-000133-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000134/0001600132-19-000134-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000135/0001600132-19-000135-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000136/0001600132-19-000136-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000141/0001600132-19-000141-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600132/000160013219000147/0001600132-19-000147-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000148/0001600132-19-000148-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000150/0001600132-19-000150-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000152/0001600132-19-000152-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000158/0001600132-19-000158-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000159/0001600132-19-000159-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000160/0001600132-19-000160-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000161/0001600132-19-000161-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000162/0001600132-19-000162-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000164/0001600132-19-000164-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000166/0001600132-19-000166-index.htm
2019-12-27PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1600132/000160013219000170/0001600132-19-000170-index.htm
2020-01-07DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000002/0001600132-20-000002-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000004/0001600132-20-000004-index.htm
2020-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000006/0001600132-20-000006-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000009/0001600132-20-000009-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000012/0001600132-20-000012-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000016/0001600132-20-000016-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000021/0001600132-20-000021-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000023/0001600132-20-000023-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000027/0001600132-20-000027-index.htm
2020-03-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600132/000160013220000030/0001600132-20-000030-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000032/0001600132-20-000032-index.htm
2020-03-31NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1600132/000160013220000034/0001600132-20-000034-index.htm
2020-04-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1600132/000160013220000039/0001600132-20-000039-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000040/0001600132-20-000040-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000043/0001600132-20-000043-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000046/0001600132-20-000046-index.htm
2020-04-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000048/0001600132-20-000048-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000056/0001600132-20-000056-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600132/000160013220000059/0001600132-20-000059-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000060/0001600132-20-000060-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000062/0001600132-20-000062-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000067/0001600132-20-000067-index.htm
2020-06-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1600132/000160013220000070/0001600132-20-000070-index.htm
2020-07-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000074/0001600132-20-000074-index.htm
2020-07-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000076/0001600132-20-000076-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000078/0001600132-20-000078-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600132/000160013220000084/0001600132-20-000084-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000085/0001600132-20-000085-index.htm
2020-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000087/0001600132-20-000087-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000089/0001600132-20-000089-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000098/0001600132-20-000098-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000099/0001600132-20-000099-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000100/0001600132-20-000100-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000101/0001600132-20-000101-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000102/0001600132-20-000102-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000103/0001600132-20-000103-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000104/0001600132-20-000104-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000105/0001600132-20-000105-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600132/000160013220000120/0001600132-20-000120-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1600132/000160013220000121/0001600132-20-000121-index.htm
2019-01-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600132/000171811119000002/0001718111-19-000002-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000171811120000001/0001718111-20-000001-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600132/000171811120000002/0001718111-20-000002-index.htm
2020-05-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600132/000171811120000003/0001718111-20-000003-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1600132/000176046020000002/0001760460-20-000002-index.htm
2020-07-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600132/999999999520001640/9999999995-20-001640-index.htm

Bellerophon Therapeutics, Inc (BLPH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bellerophon Therapeutics, Inc (BLPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 763%
Institutional Ownership: 4382%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-01-23Jonathan M PeacockDirectorBuy227,273.001,141,634.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000042/0001600132-19-000042-index.htm
2020-05-21Life Science Opportunities Fund VI Puissance10% Share HolderBuy1,153,846.0013.0014,999,998.001,153,846.00https://www.sec.gov/Archives/edgar/data/1600132/000176046020000002/0001760460-20-000002-index.htm
2018-09-25Parag Suresh ShahVP Proj Mgmt & DistributionBuy78,505.00131,599.00https://www.sec.gov/Archives/edgar/data/1600132/000160013218000145/0001600132-18-000145-index.htm
2018-09-25Martin DekkerVP of Engineering & ManufBuy82,243.00151,753.00https://www.sec.gov/Archives/edgar/data/1600132/000160013218000146/0001600132-18-000146-index.htm
2018-09-25Amy EdmondsVP Clinical Operations & AdminBuy82,243.00176,043.00https://www.sec.gov/Archives/edgar/data/1600132/000160013218000147/0001600132-18-000147-index.htm
2019-01-25Naseem AminDirectorBuy571,429.000.70400,000.301,818,867.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000041/0001600132-19-000041-index.htm
2019-01-25Jonathan M PeacockDirectorBuy714,286.000.70500,000.201,855,920.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000043/0001600132-19-000043-index.htm
2019-05-21Jonathan M PeacockDirectorBuy20,000.000.6112,198.001,875,920.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000085/0001600132-19-000085-index.htm
2020-01-23Jonathan M PeacockDirectorBuy350,000.002,225,920.00https://www.sec.gov/Archives/edgar/data/1600132/000160013220000004/0001600132-20-000004-index.htm
2020-09-10Wassim FARESChief Medical OfficerBuy4,000.0010.1840,708.004,000.00https://www.sec.gov/Archives/edgar/data/1600132/000160013220000089/0001600132-20-000089-index.htm
2019-01-25Theodore T WangDirectorBuy450,000.000.70315,000.00463,699.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000044/0001600132-19-000044-index.htm
2019-05-21Fabian TenenbaumChief Executive OfficerBuy5,000.000.602,975.00484,282.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000084/0001600132-19-000084-index.htm
2019-05-21Theodore T WangDirectorBuy43,280.000.6126,370.50506,979.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000086/0001600132-19-000086-index.htm
2019-05-22Theodore T WangDirectorBuy27,500.000.6016,533.00534,479.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000091/0001600132-19-000091-index.htm
2020-06-05Theodore T WangDirectorBuy4,986.0012.7263,441.8658,313.00https://www.sec.gov/Archives/edgar/data/1600132/000160013220000062/0001600132-20-000062-index.htm
2019-06-12Theodore T WangDirectorBuy50,000.000.6431,905.00584,479.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000097/0001600132-19-000097-index.htm
2019-11-21Theodore T WangDirectorBuy200.000.3774.00584,679.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000164/0001600132-19-000164-index.htm
2019-11-22Theodore T WangDirectorBuy1,050.000.37393.54585,729.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000164/0001600132-19-000164-index.htm
2019-11-25Theodore T WangDirectorBuy7,193.000.392,773.62592,922.00https://www.sec.gov/Archives/edgar/data/1600132/000160013219000164/0001600132-19-000164-index.htm
2020-06-08Theodore T WangDirectorBuy2,600.0012.8733,454.2060,913.00https://www.sec.gov/Archives/edgar/data/1600132/000160013220000062/0001600132-20-000062-index.htm
2019-10-28ASSOCIATES IV L P VENROCK10% Share HolderSell333,010.000.44146,091.496,435,173.00https://www.sec.gov/Archives/edgar/data/1600132/000120919119054265/0001209191-19-054265-index.htm
2019-10-25ASSOCIATES IV L P VENROCK10% Share HolderSell56,242.000.4525,511.376,768,183.00https://www.sec.gov/Archives/edgar/data/1600132/000120919119054265/0001209191-19-054265-index.htm
2019-10-24ASSOCIATES IV L P VENROCK10% Share HolderSell704,595.000.50353,354.396,824,425.00https://www.sec.gov/Archives/edgar/data/1600132/000120919119054265/0001209191-19-054265-index.htm
2019-01-23ASSOCIATES IV L P VENROCK10% Share HolderBuy142,857.000.7099,999.907,529,020.00https://www.sec.gov/Archives/edgar/data/1600132/000120919119019528/0001209191-19-019528-index.htm